Lipoic acid does not improve renal function markers in 5/6 nephrectomy model: possible role of Nrf2 inactivation

References

• Sohrabi Z, Eftekhari MH, Eskandari MH, Rezaeianzadeh A, Sagheb MM. Malnutrition-inflammation score and quality of life in hemodialysis patients: Is there any correlation? Nephrourol Mon. 2015;7(3):e27445.
   Google Scholar
• Aveles PR, Criminácio CR, Gonçalves S, et al. Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation. Nephron Clin Pract. 2010;116(4):c294–c299.
   PubMedGoogle Scholar
• Modaresi A, Nafar M, Sahraei Z. Oxidative stress in chronic kidney disease. Iran J Kidney Dis. 2015;9(3):165–179.
   PubMed Web of Science ®Google Scholar
• Fujii H, Nakai K, Fukagawa M. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial. 2011;15(2):125–128.
   PubMed Web of Science ®Google Scholar
• Rodrigues SD, França KC, Dallin FT, et al. N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system. Life Sci. 2015;121:110–116.
   PubMed Web of Science ®Google Scholar
• Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis patients: A systematic review. Kidney Int. 2012;81(3):233–246.
   PubMed Web of Science ®Google Scholar
• Chang JW, Lee EK, Kim TH, et al. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: A pilot study. Am J Nephrol. 2007;27(1):70–74.
   PubMed Web of Science ®Google Scholar
• Khabbazi T, Mahdavi R, Safa J, Pour-Abdollahi P. Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr. 2012;22(2):244–250.
   PubMed Web of Science ®Google Scholar
• El-Nakib GA, Mostafa TM, Abbas TM, El-Shishtawy MM, Mabrouk MM, Sobh MA. Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis. Int J Nephrol Renovasc Dis. 2013;27(6):161–168.
   Google Scholar
• Ramos LF, Kane J, McMonagle E, et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr. 2011;21(3):211–218.
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Mazooji N, Roozbeh J, Mazloom Z, Hasanzade J. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflammation, and malnutrition in hemodialysis patients. Iran J Kidney Dis. 2013;7(6):461–467.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Ikizler TA, Ellis C, et al. Provision of antioxidant therapy in hemodialysis (PATH): A randomized clinical trial. J Am Soc Nephrol. 2014;25(3):623–633.
   PubMed Web of Science ®Google Scholar
• Yu X, Liu H, Zou J, Zhu J, Xu X, Ding X. Oxidative stress in 5/6 nephrectomized rat model: Effect of alpha-lipoic acid. Ren Fail. 2012;34(7):907–914.
   PubMed Web of Science ®Google Scholar
• Ergür BU, Çilaker Mıcılı S, Yılmaz O, Akokay P. The effects of α-lipoic acid on aortic injury and hypertension in the rat remnant kidney (5/6 nephrectomy) model. Anatol J Cardiol. 2015;15(6):443–449.
   PubMed Web of Science ®Google Scholar
• Pradhan S, Mandal S, Roy S, Mandal A, Das K, Nandi DK. Attenuation of uremia by orally feeding alpha-lipoic acid on acetaminophen induced uremic rats. Saudi Pharm J. 2013;21(2):187–192.
   PubMed Web of Science ®Google Scholar
• Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009;1790(10):1149–1160.
   PubMed Web of Science ®Google Scholar
• Teichert J, Tuemmers T, Achenbach H, et al. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J Clin Pharmacol. 2005;45(3):313–328.
   PubMed Web of Science ®Google Scholar
• Cao Z, Tsang M, Zhao H, Li Y. Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: Protection against oxidative injury. Biochem Biophys Res Commun. 2003;310(3):979–985.
   PubMed Web of Science ®Google Scholar
• Suh JH, Shenvi SV, Dixon BM, et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA. 2004;101(10):3381–3386.
   PubMed Web of Science ®Google Scholar
• Rodrigues SD, Batista GB, Ingberman M, Pecoits-Filho R, Nakao LS. Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. Blood Purif. 2012;34(3–4):231–237.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010;298(3):F662–F671.
   PubMed Web of Science ®Google Scholar
• Aminzadeh MA, Reisman SA, Vaziri ND, et al. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease. Redox Biol. 2013;1:527–531.
   PubMed Web of Science ®Google Scholar
• Svíglerová J, Kuncová J, Nalos L, Tonar Z, Rajdl D, Stengl M. Cardiovascular parameters in rat model of chronic renal failure induced by subtotal nephrectomy. Physiol Res. 2010;59 Suppl 1:S81–S88.
   PubMed Web of Science ®Google Scholar
• Quijano C, Castro L, Peluffo G, Valez V, Radi R. Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: Direct measurements and formation of hydrogen peroxide and peroxynitrite. Am J Physiol Heart Circ Physiol. 2007;293(6):H3404–H3414.
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Bailey-Downs L, Gautam T, et al. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol. 2011;300(4):H1133–H1140.
   PubMed Web of Science ®Google Scholar
• Yoh K, Hirayama A, Ishizaki K, et al. Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells. 2008;13(11):1159–1170.
   PubMed Web of Science ®Google Scholar
• Stockler-Pinto MB, Fouque D, Soulage CO, Croze M, Mafra D. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway? J Ren Nutr. 2014;24(5):286–291.
   PubMed Web of Science ®Google Scholar
• Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013;83(6):1029–1041.
   PubMed Web of Science ®Google Scholar
• Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmac. 1997;29(3):315–331.
   PubMedGoogle Scholar
• Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C. Mechanisms of antioxidant and pro-oxidant effects of α-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int. 2005;67:1371–1380.
   PubMed Web of Science ®Google Scholar
• Yang H-C, Zuo Y, Fogo AB. Models of chronic kidney disease. Drug Discov Today Dis Models. 2010;7(1–2):13–19.
   PubMedGoogle Scholar